April 2015 Issue of The Ophthalmologist

We run the Power List to contribute, not to be controversial.

Inexpensive, high-resolution 3D printouts of orbital prosections can help ophthalmology trainees revisit basic anatomy

Nanoparticles deliver sustained corticosteroid levels to prevent corneal graft rejection

There’s still a place for retinoscopy in the diagnosis and staging of corneal ectasias

New research shows that lens epithelial cells proliferate along a narrow line, pushing older cells toward the equator and then the center of the lens

Ophthalmologists and other eye health stakeholders lobby UK Parliament to implement improved sight loss and eye health services

Novartis “embarked on a campaign to undermine” the use of bevacizumab in wet AMD, a BMJ investigation alleges.

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.

Sitting Down With… David Pyott, Chairman of the Board and Chief Executive Officer of Allergan, Inc.

The multifactorial nature of dry eye disease means that often, there’s a discordance between signs and symptoms, confounding diagnosis. Can things be improved?

Five Things We Learned This Month: